Nachrichten zur Eli Lilly & Co Aktie

Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase…

Eli Lilly stock crushed as weight loss sales, profits, disappoint Wall Street

Eli Lillys weight loss treatments have powered the company into the top ten list of megacap U.S. stocks.…

Eli Lilly shares tumble as Q3 misses estimates, guidance lowered By Investing.com

Eli Lilly shares tumble as Q3 misses estimates, guidance lowered…

Eli Lilly misses third-quarter profit amid soaring demand for weight-loss drug By Reuters

Eli Lilly misses third-quarter profit amid soaring demand for weight-loss drug…

Eli Lilly tumbles as weight loss sales underwhelm, guidance slashed

Eli Lilly and Co (NYSE:LLY) shares fell over 12% on Wednesday after the drug maker slashed guidance for the year…

A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years @themotleyfool #stocks $LLY $NVO

Eli Lilly has a number of lucrative opportunities that should serve as tailwinds for sustained growth.…

Nasdaq and S&P 500 retreat from record highs, SuperMicro and Eli Lilly dive, Alphabet jumps

9.48am: Stocks open lower, led by S&P and Nasdaq Wall Streets main indices have stumbled in early treading. The Dow…

Is Eli Lilly Stock a Buy?

Eli Lilly has been a huge winner with its GLP-1 drugs.…

Lillys Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks

Eli Lilly misses third-quarter estimates for earnings and sales. Mounjaro and Zepbound sales also miss estimates. Stock declines 11%.…

5 Things to Know Before the Stock Market Opens

Google-parent Alphabet shares climb after cloud revenue boosts earnings, AMD stock drops on a weak sales outlook, and Eli Lilly…

Eli Lilly shares could be set for a big move if the Zepbound maker adds to its winning streak

The pharmaceuticals giant has exceeded Wall Streets expectations for five straight quarters, helped by the success of its GLP-1 drugs…

1 Huge New Reason to Buy Eli Lilly or Novo Nordisk Stock Right Now and Hold It Forever @themotleyfool #stocks $LLY $NVO

One key disease-prevention market is drawing closer to being within reach.…

1 Huge New Reason to Buy Eli Lilly or Novo Nordisk Stock Right Now and Hold It Forever

One key disease-prevention market is drawing closer to being within reach.…

Eli Lillys Latest Setback Could Portend an Unexpected Headwind for the Stock

The odds of its new drug getting established in the U.K. are now much lower.…

Eli Lillys Latest Setback Could Portend an Unexpected Headwind for the Stock @themotleyfool #stocks $LLY

The odds of its new drug getting established in the U.K. are now much lower.…

Eli Lilly’s weight-loss drug Mounjaro set for Hong Kong launch

Eli Lilly’s weight-loss drug Mounjaro set for Hong Kong launch - report…

Eli Lilly gets nod to sell weight-loss drug in Hong Kong by year-end - report

…

Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News By Reuters

Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News…

Billionaire Stanley Druckenmiller Closed Out His Position in Eli Lilly Stock. 3 Reasons Why Im Still a Buyer.

Stanley Druckenmillers Duquesne Family Office exited its position in Eli Lilly stock last quarter.…

What To Expect in the Markets This Week

Coming up: Amazon, Exxon, and Eli Lilly earnings, September jobs report, Consumer Spending Inflation, GDP…

This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lillys Stock

Fewer contenders means fewer constraints on expanding market share.…

This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lillys Stock @themotleyfool #stocks $JNJ $LLY $BIIB

Fewer contenders means fewer constraints on expanding market share.…

Lilly sues online vendors, medical spa over copycat weight-loss drugs

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound,…

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company…

Eli Lilly Buy On Weakness Signal (Technical Analysis)

…

1 Reason to Buy Eli Lilly Stock Hand Over Fist Right Now

Eli Lilly just secured a huge win, and its not related to the weight loss industry.…

This is Huge News For Eli Lilly Investors

Eli Lilly is investing billions into new research and manufacturing capabilities.…

This is Huge News For Eli Lilly Investors @themotleyfool #stocks $LLY

Eli Lilly is investing billions into new research and manufacturing capabilities.…

3 Reasons Eli Lilly Stock Isnt Going to Run out of Steam Anytime Soon @themotleyfool #stocks $LLY

Eli Lillys valuation could look much more modest in the future, as its earnings should continue to grow at a…

3 Reasons Eli Lilly Stock Isnt Going to Run out of Steam Anytime Soon

Eli Lillys valuation could look much more modest in the future, as its earnings should continue to grow at a…

Why The 22% Two-Day Rally For Hims & Hers Stock Is At Risk

Hims & Hers has enjoyed a rally on an FDA decision regarding Eli Lillys tirzepatide.…

Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?

These are two of healthcares biggest darlings right now, but one looks better positioned for the long run.…

Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years? @themotleyfool #stocks $LLY $NVO

These are two of healthcares biggest darlings right now, but one looks better positioned for the long run.…

dpa-AFX ProFeed